Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析

◆英語タイトル:Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15780
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Corcept Therapeutics Inc (CORT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Corcept’s lead product candidate Korlym (mifepristone) is the first drug candidate to be approved for the treatment of patients with Cushing’s syndrome. Other products in the pipeline include mifepristone for psychotic depression; CORT 108297 and other GR antagonists that help in the prevention of antipsychotic-induced weight gain mitigation. Corcept is headquartered in Menlo Park, California, the US.

Corcept Therapeutics Inc Key Recent Developments

Mar 18,2019 Corcept Therapeutics names Andreas Grauer, M.D., as chief medical officer
Feb 25,2019 Corcept Therapeutics announces fourth quarter and full-year 2018 audited financial results and provides corporate update
Feb 05,2019 Kaplan Fox investigates Corcept Therapeutics
Jan 31,2019 Corcept Therapeutics announces fourth quarter and full-year 2018 preliminary selected financial results; provides 2019 revenue guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Corcept Therapeutics Inc – Key Facts
Corcept Therapeutics Inc – Key Employees
Corcept Therapeutics Inc – Key Employee Biographies
Corcept Therapeutics Inc – Major Products and Services
Corcept Therapeutics Inc – History
Corcept Therapeutics Inc – Company Statement
Corcept Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Corcept Therapeutics Inc – Business Description
Corcept Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Corcept Therapeutics Inc – Strengths
Corcept Therapeutics Inc – Weaknesses
Corcept Therapeutics Inc – Opportunities
Corcept Therapeutics Inc – Threats
Corcept Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Corcept Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 18, 2019: Corcept Therapeutics names Andreas Grauer, M.D., as chief medical officer
Feb 25, 2019: Corcept Therapeutics announces fourth quarter and full-year 2018 audited financial results and provides corporate update
Feb 05, 2019: Kaplan Fox investigates Corcept Therapeutics
Jan 31, 2019: Corcept Therapeutics announces fourth quarter and full-year 2018 preliminary selected financial results; provides 2019 revenue guidance
Nov 01, 2018: Corcept Therapeutics announces third quarter 2018 financial results and provides corporate update
Aug 09, 2018: Corcept Therapeutics announces second quarter 2018 financial results and stock repurchase program; Provides clinical update
May 08, 2018: Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update
Feb 22, 2018: Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
Feb 01, 2018: Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Corcept Therapeutics Inc, Key Facts
Corcept Therapeutics Inc, Key Employees
Corcept Therapeutics Inc, Key Employee Biographies
Corcept Therapeutics Inc, Major Products and Services
Corcept Therapeutics Inc, History
Corcept Therapeutics Inc, Subsidiaries
Corcept Therapeutics Inc, Key Competitors
Corcept Therapeutics Inc, Ratios based on current share price
Corcept Therapeutics Inc, Annual Ratios
Corcept Therapeutics Inc, Annual Ratios (Cont...1)
Corcept Therapeutics Inc, Annual Ratios (Cont...2)
Corcept Therapeutics Inc, Interim Ratios
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Corcept Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Corcept Therapeutics Inc, Performance Chart (2014 - 2018)
Corcept Therapeutics Inc, Ratio Charts
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WorldPay US Inc:企業の戦略・SWOT・財務情報
    WorldPay US Inc - Strategy, SWOT and Corporate Finance Report Summary WorldPay US Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Capevin Investments Limited:企業の戦略・SWOT・財務分析
    SummaryCapevin Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Kansas City Power & Light Co:企業の発電所・SWOT分析2018
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Punch Taverns plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Punch Taverns plc Mergers and A …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Beijing Tianrun New Energy Investment Co., Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Beijing Tianrun New Energy Investment Co., Ltd. (Tianrun New Energy), a subsidiary of Xinjiang Goldwind Science & Technology Co., Ltd, is a renewable energy company that provides various services to wind power sector. The company offers services like consulting, planning, development, invest …
  • KapStone Paper and Packaging Corporation:企業の戦略・SWOT・財務情報
    KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Penske Automotive Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Penske Automotive Group, Inc. M …
  • Great Eastern Energy Corporation Ltd. (GEEC):企業の財務及び戦略的SWOT分析
    Summary Great Eastern Energy Corporation Ltd. (GEECL) is an exploration company that offers production of oil and gas properties. The company explores, develops, distributes and markets coalbed methane gas. It operates upstream, midstream and downstream projects in Raniganj south block, and Mannargu …
  • Sylvania Resources Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sylvania Resources Limited Merg …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • OC Oerlikon Balzers AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OC Oerlikon Balzers AG Mergers …
  • Sysmex Corporation (6869):企業の財務及び戦略的SWOT分析
    Sysmex Corporation (6869) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sebia SA:企業のM&A・提携動向(医療機器分野)
    Summary Sebia SA(Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program are automated system for capillary electrophoresis, gel electrophoresis and electrophoresis s …
  • Gammon Infrastructure Projects Limited (GAMMNINFRA):企業のM&A・提携動向(発電分野)
    Summary Gammon Infrastructure Projects Limited (GIPL) is an infrastructure project development company. It undertakes projects on a public private partnership basis (PPP) across various sectors including hydro power, roads and expressways, ports, urban infrastructure, airports, special economic zone …
  • China Three Gorges Corporation:企業のM&A・提携動向(発電分野)
    Summary China Three Gorges Corporation (CTG), formerly known as China Three Gorges Project Corporation, is an energy group that concentrates on developing and operating hydropower generation plants. The company's operations comprise hydropower project engineering, construction and management, electr …
  • Palatin Technologies Inc (PTN):製薬・医療:M&Aディール及び事業提携情報
    Summary Palatin Technologies Inc (Palatin) is a biopharmaceutical company that undertakes the development of targeted, receptor-specific peptide therapeutics. The company’s development programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor sys …
  • Wirecard AG:企業のM&A・事業提携・投資動向
    Wirecard AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wirecard AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Denator AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Denator AB Mergers and Acquisit …
  • Kancera AB (KAN):企業財務及び戦略的SWOT分析
    Summary Kancera AB (Kancera) is a biotechnology company that develops new drugs for cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping ener …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆